Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) EPS (Weighted Average and Diluted) (2020 - 2025)

Rapid Micro Biosystems' EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at -$0.26 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) changed 0.0% year-over-year to -$0.26; the TTM value through Sep 2025 reached -$1.0, up 10.71%, while the annual FY2024 figure was -$1.08, 11.48% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.26 at Rapid Micro Biosystems, roughly flat from -$0.26 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.2 in Q4 2021 and bottomed at -$37.89 in Q1 2021.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.31 (2023), against an average of -$3.26.
  • The largest annual shift saw EPS (Weighted Average and Diluted) soared 103.16% in 2021 before it plummeted 131.67% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.2 in 2021, then tumbled by 131.67% to -$0.38 in 2022, then soared by 31.58% to -$0.26 in 2023, then increased by 15.38% to -$0.22 in 2024, then fell by 18.18% to -$0.26 in 2025.
  • Per Business Quant, the three most recent readings for RPID's EPS (Weighted Average and Diluted) are -$0.26 (Q3 2025), -$0.26 (Q2 2025), and -$0.26 (Q1 2025).